tiprankstipranks
Trending News
More News >
BioVaxys Technology (TSE:BIOV)
:BIOV
Canadian Market

BioVaxys Technology (BIOV) Income Statement

Compare
19 Followers

BioVaxys Technology Income Statement

Last quarter (Q3 2025), BioVaxys Technology's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, BioVaxys Technology's net income was C$-910.06K. See BioVaxys Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 3.30MC$ 2.40MC$ 4.08MC$ 6.44MC$ 1.10M
Depreciation and Amortization
C$ 0.00C$ 2.40MC$ 3.80MC$ 39.47KC$ 8.62K
EBITDA
C$ -3.95MC$ -7.69MC$ 0.00C$ -6.42MC$ -1.09M
Operating Income
C$ -3.30MC$ -2.40MC$ -4.08MC$ -6.44MC$ -1.10M
Other Income/Expenses
C$ -659.26KC$ -5.28MC$ -7.65MC$ -15.91KC$ -4.24K
Pretax Income
C$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10M
Net Income
C$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17M
Per Share Metrics
Basic EPS
C$ -0.20C$ -0.57C$ -1.20C$ -0.78C$ -0.42
Diluted EPS
C$ -0.20C$ -0.57C$ -1.20C$ -0.78C$ -0.42
Weighted Average Shares Outstanding
19.57M 13.41M 9.82M 8.29M 3.00M
Weighted Average Shares Outstanding (Diluted)
19.57M 13.41M 9.82M 8.29M 2.82M
Currency in CAD

BioVaxys Technology Earnings and Revenue History